Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Clinical trial NCT02531633 · TERMINATED
Trial details
- NCT number
- NCT02531633
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-16
- Primary completion
- 2018-03-21
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.